A detailed history of Y Intercept (Hong Kong) LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 38,688 shares of AZN stock, worth $2.49 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
38,688
Previous 20,176 91.75%
Holding current value
$2.49 Million
Previous $1.57 Million 91.61%
% of portfolio
0.19%
Previous 0.09%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$76.67 - $87.62 $1.42 Million - $1.62 Million
18,512 Added 91.75%
38,688 $3.01 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $1.35 Million - $1.63 Million
20,176 New
20,176 $1.57 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $964,184 - $1.08 Million
15,579 New
15,579 $1.05 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $2.61 Million - $2.83 Million
37,268 New
37,268 $2.67 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $602,869 - $783,363
11,121 New
11,121 $754,000
Q2 2021

Aug 12, 2021

SELL
$48.42 - $60.18 $926,710 - $1.15 Million
-19,139 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$47.16 - $54.44 $902,595 - $1.04 Million
19,139 New
19,139 $956,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.